|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,644.88 |
3.31% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$61,377.30 |
2.91% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$53,239.71 |
2.53% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$49,987.73 |
2.37% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$48,332.70 |
2.30% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,243.25 |
2.29% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$46,584.18 |
2.21% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,170.74 |
2.19% |
| Waters Corporation |
WAT |
941848103 |
120 |
$45,363.60 |
2.15% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,081.43 |
2.14% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,293.48 |
2.10% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,145.55 |
2.10% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$44,288.50 |
2.10% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,025.00 |
2.09% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$43,898.33 |
2.08% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$43,712.93 |
2.08% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$43,500.48 |
2.07% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,477.81 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,155.08 |
2.05% |
| Steris Plc |
STE |
G8473T100 |
169 |
$42,983.46 |
2.04% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$41,856.26 |
1.99% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,426.08 |
1.97% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$41,227.34 |
1.96% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$41,323.52 |
1.96% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,022.11 |
1.95% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$40,711.26 |
1.93% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$40,405.02 |
1.92% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$40,428.72 |
1.92% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$40,074.08 |
1.90% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$39,964.98 |
1.90% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$39,017.54 |
1.85% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$38,682.03 |
1.84% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,716.80 |
1.84% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$38,206.03 |
1.81% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$37,898.29 |
1.80% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$37,990.22 |
1.80% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$37,760.45 |
1.79% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$37,681.82 |
1.79% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$37,385.56 |
1.78% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$37,523.73 |
1.78% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,206.09 |
1.77% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$37,350.56 |
1.77% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,280.12 |
1.77% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$36,995.04 |
1.76% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$36,781.74 |
1.75% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$36,882.95 |
1.75% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$36,718.70 |
1.74% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,006.18 |
1.71% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$34,450.32 |
1.64% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,196.20 |
1.53% |
| US Dollar |
$USD |
|
3,083 |
$3,082.95 |
0.15% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|